A new panel of U.S. vaccine advisers appointed by Health Secretary Robert F. Kennedy Jr. will vote on flu shots that contain ...

Investing.com -- Shares of AstraZeneca (ST: AZN) and GlaxoSmithKline (LON: GSK) fell Tuesday after former U.S. President ...

The global preventive healthcare technologies market, valued at $296.48 billion in 2024, is set to hit $1.19 trillion by 2034 ...

GlaxoSmithKline Pharmaceuticals, with its shares currently priced at Rs 3,292.30, remains a key stock to watch, particularly ...

During a live event, Binod Dhakal, MD, and participants discussed their experience using selinexor in the second line and ...

WASHINGTON - The Food and Drug Administration on Wednesday approved Gilead Sciences' lenacapavir, a twice-yearly injection ...

Ticks are spreading globally and bringing familiar conditions such as Lyme disease with them, as well as totally new ones.

The Government has announced a 'significant' shake-up to the childhood vaccination schedule this year. Here's what parents ...

Dr. Stephana Julia Moss, an investigator at the Canadian Center for Vaccinology (CCfV), Dalhousie University, has been ...

Early intervention in high-risk smoldering myeloma with lenalidomide delays progression by up to 7 years and achieves ...

At ASCO 2025, an expert discusses encouraging new early-phase research in clinical trials on treating myeloma.

The strong financials and positive sentiment may have contributed to GlaxoSmithKline Pharmaceutical's stock reaching a new 52-week high.